14.08.2012 Views

Labelling Review row-Online

Labelling Review row-Online

Labelling Review row-Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Mast Cell Tryptase<br />

Clone 10D11<br />

7 mL Bond ready-to-use PA0019 P<br />

For In Vitro Diagnostic Use<br />

Mast cells contain a number of preformed chemical mediators such as<br />

histamine, chymase, carboxypeptidase and proteolytic tryptase. A<br />

substantial quantity of tryptase is reported to be found in mast cells of skin<br />

and lung and suggests this enzyme plays a major role in mast cell mediated<br />

events. In vitro studies indicate tryptase can cleave C3 to form C3a<br />

anaphylatoxin, inactivate fibrinogen as a coaguable substrate for thrombin<br />

and activate latent collagenase. Models of allergenic disease in the skin,<br />

nose and lung have each indicated elevated tryptase levels. Human mast<br />

cell tryptase has been reported to be implicated as a mediator of<br />

inflammation. Mast cell degranulation in the gut causes mucus secretion,<br />

mucosal edema, increased gut permeability and may be responsible for<br />

some of the symptoms and signs of inflammatory bowel disease.<br />

Also available as a Novocastra concentrate, refer to page 130.<br />

Bowel: immunohistochemical staining with Bond ready-to-use Mast Cell Tryptase (10D11)<br />

using Bond Polymer Refine Detection.<br />

Melan A<br />

Clone A103<br />

7 mL Bond ready-to-use PA0233 P (HIER)<br />

For In Vitro Diagnostic Use<br />

Melan A, a product of the MART-1 gene, is a melanocytic differentiation<br />

marker recognized by autologous cytotoxic T lymphocytes.<br />

Product Specific Information<br />

Melan A (A103) is employed in the assessment of Melan A in melanocytic<br />

lesions.<br />

Also available as a Novocastra concentrate, refer to page 132.<br />

Malignant melanoma: immunohistochemical staining with Bond ready-to-use Melan A (A013)<br />

using Bond Polymer Refine Detection.<br />

Mesothelin<br />

Clone 5B2<br />

7 mL Bond ready-to-use PA0373 P (HIER)<br />

For In Vitro Diagnostic Use<br />

Mesothelin is present on the surface of mesothelial cells, mesothelioma,<br />

epithelial ovarian cancers and some squamous cell carcinomas. Mesothelin<br />

is abundantly expressed in the kidney and in occasional epithelial cells of<br />

the trachea, tonsil and fallopian tube. The function of mesothelin is unclear<br />

but it may have a role in cellular adhesion.<br />

Product Specific Information<br />

Mesothelin is reported to be abundant in the normal mesothelial cells from<br />

which malignant mesothelioma and ovarian cystadenocarcinomas are<br />

derived. As such, Bond ready-to-use Mesothelin (5B2) is recommended for<br />

use as part of a panel of antibodies to distinguish mesotheliomas and ovarian<br />

cystadenocarcinomas from other solid tumors.<br />

Mesothelin (5B2) is recommended for use as part of a panel of antibodies to<br />

distinguish mesotheliomas and ovarian cystadenocarcinomas from other<br />

solid tumors.<br />

Also available as a Novocastra concentrate, refer to page 133.<br />

Mesothelioma: immunohistochemical staining with Bond ready-to-use Mesothelin (5B2) using<br />

Bond Polymer Refine Detection.<br />

MLH1 (Mismatch Repair Protein)<br />

Clone ES05 New!<br />

7 mL Bond ready-to-use PA0610 P (HIER)<br />

For In Vitro Diagnostic Use<br />

MLH1, a mismatch repair protein involved in maintaining the integrity of<br />

genetic information, alongside MSH2, MSH6 and PMS2. During DNA<br />

replication, strand misalignment can occur resulting in alterations to<br />

microsatellite repeats, often referred to as microsatellite instability (MSI).<br />

These defects in DNA repair pathways have been linked to human<br />

carcinogenesis. Mutations in the MLH1 gene have been reported to be<br />

found in tumors with MSI, such as some forms of colon cancer eg<br />

Hereditary nonpolyposis colon cancer (HNPCC), a subset of sporadic<br />

carcinomas and breast cancer. Loss of expression of MLH1 has also been<br />

reported in acute lymphoblastic leukemia, endometrial carcinoma, gastric<br />

carcinoma and ovarian carcinoma.<br />

Also available as a Novocastra concentrate, refer to page 134.<br />

F Frozen I Immunofluorescence E Electron microscopy<br />

P Paraffin C Flow cytometry O Other applications<br />

W Western blotting<br />

/33<br />

Bond

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!